MedTrace Logo

Assesment of TDApp1 an eHelath Tool to Make Therapeutic Recommendations for Patients With ADHD

NCT04228094 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 33

Last updated 2022-09-22

No results posted yet for this study

Summary

This is a 3-week open label, one group study to determine the agreement between the pharmacological treatment recommended by TDApp1 and the interventions recommended by relevant clinical practice guidelines.

Conditions

  • Attention Deficit-hyperactivity Disorder

Interventions

OTHER

TDApp1: an eHealth intervention

TDApp1 is a tool that uses GRADE heuristics to formulate participatory, individualized and automated therapeutic recommendations for patients with Attention Deficit Hyperactivity Disorder

Sponsors & Collaborators

  • Universitat de Girona

    lead OTHER

Principal Investigators

  • Xavier Castells, MD, PhD · Universitat de Girona

Eligibility

Min Age
6 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-10
Primary Completion
2022-05-09
Completion
2022-05-09

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04228094 on ClinicalTrials.gov